The Impact of COVID-19 on Contracts and Corporate Activities: Your Questions Answered
Client Alert | 1 min read | 05.05.20
In response to the many questions we have recently received from clients, we have prepared a Q&A regarding the impact of the COVID-19 pandemic on various day-to-day business activities in Belgium. In particular, we address the following specific questions:
- Can you suspend or terminate a contract without penalty as a result of COVID-19?
- How can you hold a general meeting or a board meeting that respects social distancing?
- What measures have been taken by the Belgian government to support businesses?
- What is the best way to sign contracts electronically?
The questions and answers in this Q&A are of course of a general nature and should not be considered to be comprehensive legal advice on specific questions and/or cases. Do not hesitate to contact our team if you have any specific questions and/or would like any advice with regard to a concrete situation.
In addition, Crowell & Moring Brussels recently launched its “COVID-19 Virtual Assistant.” This virtual tool allows you to navigate the rapidly evolving regulations adopted by the Belgian federal and regional governments in the wake of the pandemic. Our Virtual Assistant can be consulted free of charge and can be accessed via our Coronavirus Resource Center on our website.
For the Dutch version of the Q&A, please click here. The French version can be found here.
Contacts
Insights
Client Alert | 5 min read | 10.22.26
CMS Proposes Major Changes to MA, Part D, and PBM Requirements
On October 16, 2026, the U.S. Centers for Medicare and Medicaid Services (CMS) issued a proposed rule implementing key sections of the Consolidated Appropriations Act (CAA) of 2026, Section 6224 (“Modernizing and Ensuring Pharmacy Benefit Manager Accountability”). The agency also proposes a conforming change mandated by section 6219 of the CAA (“Adjustments to Medicare Part D Cost-Sharing Reductions for Low-Income Individuals”) that would reduce the generic-drug copayment from $1 to $0 for full-benefit dual eligible individuals. Comments to the proposed rule are due December 15, 2026.
Client Alert | 4 min read | 10.22.26
When the Clock Strikes Twice: Crocs Takes Piecemeal ITC Appeals to the Supreme Court
Client Alert | 9 min read | 10.21.26
Client Alert | 2 min read | 10.21.26
